NIH Office of Technology Transfer (OTT)

Neglected Diseases

Technologies Available for Licensing from NIH/FDA

Dracunculiasis

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Fascioliasis

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Hookworm

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Lymphatic filariasis

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Onchocerciasis

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Roundworm

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Schistosomiasis

Alleviating Symptoms of Th2-Like Cytokine Mediated Disorders by Reducing IL-13 Receptor-Expressing Cells in the Respiratory Tract

This invention relates to the alleviation of symptoms of Th2-like cytokine mediated disorders, such as allergy, asthma, and to hyperinflammatory responses in the respiratory tract to infectious diseases and parasitic infections, including tuberculosis, schistosomiasis, leishmania, and filariasis.

This invention claims a variety of methods and uses of a chimeric molecule comprising a toxic moiety and a targeting moiety that specificall... More ...

Whipworm

No NIH/FDA Technology Abstracts are available for this Neglected Disease/Condition at this time.

Technologies Available for Licensing from Non-Profit Institutions

Lymphatic filariasis
Massachusetts General Hospital Polynucleotides And Polypeptides For Molting And Uses Thereof
Schistosomiasis
University of Massachusetts at Amherst A New Vaccine For Protection Of Children And Adults Against Schistosomiasis

Bacterial Infections	Helminthic Infections	Protozoan Infections
Viral Infections

	Overview
	Dracunculiasis
	Fascioliasis
	Hookworm
	Lymphatic filariasis
	Onchocerciasis
	Roundworm
	Schistosomiasis
	Whipworm